This Week in Managed Care: March 24, 2017
Source: This Week in Managed Care: March 24, 2017
A protein can boost blood stem cells, making them behave like those of younger people. Is it the key to harnessing young blood’s rejuvenating power?
Source: Old blood can be made young again and it might fight ageing | New Scientist
It can be quite a shock to start learning to connect with people without the social lubricant of alcohol. But it’s totally worth the effort.
Source: Biet Simkin & Olessa Pindak Talk Sober Socializing – mindbodygreen
Two Advisory Board research leaders discuss the current state of precision medicine – and what it will take for genomics to become part of routine care.
Source: 5 big challenges to utilizing genomic data for precision medicine | Healthcare IT News
Here are the problems with the House plan to repeal and replace Obamacare.
Source: The Failures of the American Health Care Act – Reason.com
When you spend your own money on yourself, you try to maximize quality while minimizing cost. When you’re spending other people’s money on other people, you aren’t concerned with either quality or cost.
Source: Why Single-Payer Health Care Delivers Poor Quality at High Cost | Foundation for Economic Education
Tattoos that turn skin into a touchscreen could display notifications on your body and let you answer a call or pump up the volume with a tap of your fingers
Source: E-tattoos turn knuckles and freckles into smartphone controls | New Scientist
A woman in her 80s has become the first person to be successfully treated with induced pluripotent stem (iPS) cells. A slither of laboratory-made retinal cells has protected her eyesight, fighting her age-related macular degeneration – a common form of progressive blindness.
Source: Vision saved by first induced pluripotent stem cell treatment | New Scientist
The first results of gene editing in viable human embryos reveals it works better than we thought, but that there’s another big problem blocking the way
Source: Mosaic problem stands in the way of gene editing embryos | New Scientist